Evidence map›Paper›PMID 22228169›Full record

Trial reportDiseases of the colon and rectum2012

Reverse-hybrid robotic mesorectal excision for rectal cancer.

In Ja Park, Y Nancy You, Erika Schlette, Sa Nguyen, John M Skibber, Miguel A Rodriguez-Bigas, George J Chang

Abstract readClinical Trial
In one paragraph

Trial report in Diseases of the colon and rectum, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Outcomes of robotic-assisted colorectal surgery compared with laparoscopic and open surgery: a systematic review.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2014
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Robotic rectal surgery: State of the art.World journal of gastrointestinal oncology · 2016
    Review
  9. Article
  10. Robotic Surgery for Colon and Rectal Cancer.Current oncology reports · 2016
    Review
  11. Article
  12. Article
  13. Robotic surgery for rectal cancer: A systematic review of current practice.World journal of gastrointestinal oncology · 2014
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

In Ja ParkDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TC 77230, USA.
Y Nancy You
Erika Schlette
Sa Nguyen
John M Skibber
Miguel A Rodriguez-Bigas
George J Chang
The University of Texas MD Anderson Cancer Center · US

Funding

Optimizing Treatment of Rectal Cancer Using a Markov Decision ModelK07CA133187 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHANG, GEORGE J · 2009 to 2013
$853k
NCI NIH HHS K07 CA133187NCI NIH HHS K07-CA133187
6 · The paper itself

Abstract

purposeThe robotic system offers potential technical advantages over laparoscopy for total mesorectal excision with radical lymphadenectomy for rectal cancer. However, the requirement for fixed docking limits its utility when the working volume is large or patient repositioning is required. The purpose of this study was to evaluate short-term outcomes associated with a novel setup to perform total mesorectal excision and radical lymphadenectomy for rectal cancer by the use of a "reverse" hybrid robotic-laparoscopic approach.

methodsThis is a prospective consecutive cohort observational study of patients who underwent robotic rectal cancer resection from January 2009 to March 2011. During the study period, a technique of reverse-hybrid robotic-laparoscopic rectal resection with radical lymphadenectomy was developed. This technique involves reversal of the operative sequence with lymphovascular and rectal dissection to precede proximal colonic mobilization. This technique evolved from a conventional-hybrid resection with laparoscopic vascular control, colonic mobilization, and robotic pelvic dissection. Perioperative and short-term oncologic outcomes were analyzed.

resultsThirty patients underwent reverse-hybrid resection. Median tumor location was 5 cm (interquartile range 3-9) from the anal verge. Median BMI was 27.6 (interquartile range 25.0-32.1 kg/m). Twenty (66.7%) received neoadjuvant chemoradiation. There were no conversions. Median blood loss was 100 mL (interquartile range 75-200). Total operation time was a median 369 (interquartile range 306-410) minutes. Median docking time was 6 (interquartile range 5-8) minutes, and console time was 98 (interquartile range 88-140) minutes. Resection was R0 in all patients; no patients had an incomplete mesorectal resection. Six patients (20%) underwent extended lymph node dissection or en bloc resection.

conclusionsReverse-hybrid robotic surgery for rectal cancer maximizes the therapeutic applicability of the robotic and conventional laparoscopic techniques for optimized application in minimally invasive rectal surgery.

Indexed as

RoboticsAdenocarcinomaAgedFemaleHumansLaparoscopyLymph Node ExcisionMaleMiddle AgedMinimally Invasive Surgical ProceduresPostoperative ComplicationsProspective StudiesRectal NeoplasmsRectumTime FactorsTreatment Outcome

Identifiers

PMID22228169
PMCPMC3546550
OpenAlexW2049515180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.